• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Addressing Concerns About the Financial Impact of Amyloid-Targeting Therapies

Opinion
Video

Panelists discuss how the substantial financial impact of amyloid-targeting therapies necessitates innovative approaches including value-based pricing models, outcomes-based contracts, risk-sharing arrangements between payers and manufacturers, stratified patient selection criteria, and system-level solutions to balance clinical benefit with economic sustainability for health care systems, insurers, and patients.

Related Videos
Dr Brian Slomovitz
5 experts in this video
4 experts are featured in this series.
5 experts in this video
4 experts are featured in this series.
Dr CK Wang
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.